PPA
NAGE

Parametric Portfolio Associates’s Niagen Bioscience NAGE Stock Holding History

Parametric Portfolio Associates’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$31K Buy
12,472
+650
+5% +$1.78K ﹤0.01% 3650
2021
Q4 		$44K Sell
11,822
-46,090
-80% -$249K ﹤0.01% 3605
2021
Q3 		$363K Sell
57,912
-28
-0% -$231 ﹤0.01% 3223
2021
Q2 		$571K Buy
57,940
+3,973
+7% +$34.6K ﹤0.01% 3025
2021
Q1 		$504K Buy
53,967
+5,054
+10% +$40.1K ﹤0.01% 3496
2020
Q4 		$235K Buy
48,913
+28,941
+145% +$141K ﹤0.01% 3708
2020
Q3 		$80K Buy
+19,972
New +$96.3K ﹤0.01% 3823

Other funds holding NAGE

YRHAM
Yong Rong (HK) Asset Management Sheung Wan, Hong Kong $119M AUM 233.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $3.47B AUM 23.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Parametric Portfolio Associates's NAGE Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Niagen Bioscience (NAGE) stake by 5.5% in Q1 2022, buying an estimated $1.78K and bringing the position to 12,472 shares worth $31K. The position accounts for ﹤0.01% of the portfolio, ranked #3650.

Parametric Portfolio Associates first reported a position in NAGE in Q3 2020 and has held it in 7 quarters since. The position peaked at $571K in Q2 2021. 82 funds tracked by Wall St. Rank hold NAGE as of Q1 2022.

  • Parametric Portfolio Associates held 12,472 shares of Niagen Bioscience worth $31K as of Q1 2022.
  • Parametric Portfolio Associates bought 650 Niagen Bioscience shares in Q1 2022, an estimated $1.78K.
  • Niagen Bioscience made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3650 holding.
  • Parametric Portfolio Associates first reported a position in Niagen Bioscience in Q3 2020 and has held it in 7 quarters since.
  • Parametric Portfolio Associates's Niagen Bioscience position peaked at $571K in Q2 2021.
  • 82 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.